Evidence map›Paper›PMID 32724617›Full record

ArticleFood science & nutrition2020

Enhanced oral bioavailability and bioefficacy of phloretin using mixed polymeric modified self-nanoemulsions.

Yiling Wang, Dongli Li, Huiqiong Lin, Sen Jiang, Lei Han, Shuli Hou, Shuying Lin, Zhefeng Cheng, Wangqing Bian, Xinxin Zhang and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Computational Identification of New Dual PAK4 and NAMPT Inhibitors.International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Inhibition of NAMPT by PAK4 Inhibitors.International journal of molecular sciences · 2024
    Article
  10. Article
  11. Article
  12. Optimization of Phloretin-loaded Nanospanlastics for Targeting ofCurrent pharmaceutical biotechnology · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yiling WangSchool of Biotechnology and Health Science Wuyi University Jiangmen China.ORCID https://orcid.org/0000-0001-5380-6022
Dongli LiSchool of Biotechnology and Health Science Wuyi University Jiangmen China.
Huiqiong LinSchool of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China.
Sen JiangSchool of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China.
Lei HanSchool of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China.
Shuli HouSchool of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China.
Shuying LinSchool of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China.
Zhefeng ChengSchool of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China.
Wangqing BianSchool of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China.
Xinxin ZhangShanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China.
Yan HeSchool of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China.
Kun ZhangSchool of Biotechnology and Health Science Wuyi University Jiangmen China.
Guangdong University of Technology · CNWuyi University · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phloretin (Ph) is a natural active ingredient with wide biological properties. However, its poor water-solubility and low oral bioavailability limit the application significantly in functional food and drug. This study was to explore the mixed polymer Pluronic® F127 and P123 modified the different triglycerides (LCT, MCT, SCT) in self-nanoemulsions (SNEs) for enhancing the oral bioavailability and bioefficacy of Ph. The SNEs were characterized in terms of physical property study, lipolysis study, pharmacokinetic study, and anti-inflammatory effect. The water-solubility of LCT-Ph-SNE increased 3000-fold compared with Ph solution. Pharmacokinetic study of SNEs and other carriers (HP-β-CD, PVP) results indicated that LCT-Ph-SNE was 7.9-fold more bioavailable compared with unformulated Ph. The anti-inflammatory activity of LCT-Ph-SNE in vivo represented a 6.8-fold enhancement compared with unformulated Ph. This novel SNE formulation may also be used for other poorly soluble ingredients with high loading capacity, which made a significant impact on functional food and drug.

Indexed as

anti‐inflammatorybioavailabilitypharmacokineticsphloretinself‐nanoemulsionssolubility

Identifiers

PMID32724617
PMCPMC7382203
OpenAlexW3030684663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.